INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 129 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | -10.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -16.7% | 2,500 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $12,000 | +20.0% | 2,500 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $10,000 | -16.7% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | +20.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | -37.5% | 2,500 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $16,000 | -20.0% | 2,500 | 0.0% | 0.01% | -25.0% |
| Q2 2017 | $20,000 | +17.6% | 2,500 | 0.0% | 0.01% | +14.3% |
| Q1 2017 | $17,000 | -15.0% | 2,500 | -13.0% | 0.01% | -22.2% |
| Q4 2016 | $20,000 | -25.9% | 2,875 | 0.0% | 0.01% | -30.8% |
| Q3 2016 | $27,000 | 0.0% | 2,875 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $27,000 | +8.0% | 2,875 | 0.0% | 0.01% | +8.3% |
| Q1 2016 | $25,000 | +31.6% | 2,875 | 0.0% | 0.01% | +50.0% |
| Q4 2015 | $19,000 | – | 2,875 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |